Meanwhile, serum biomarkers (e.g., alpha-fetoprotein [AFP], des-gamma-carboxy prothrombin [DCP]) reflect tumor biological behavior and therapeutic response, functioning as key quantitative indicators for dynamic efficacy evaluation (6). Here, AFP is linked to neoplasm.